Targeting the JAK2V617F hematopoietic stem cell through integrins-based combination
Advancing Research: Targeting the JAK2V617F Hematopoietic Stem Cell Through Integrins-Based Combination Early in her career, as a veterinarian, Shinobu Matsuura, DVM, PhD, remembers a debilitating